Last Updated:
Name Designation Appointment Date Status
Rajiv Limboo

Appointed as Director since May 2010

Director 26-May-2010 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Nirmal Kumar Tamang

Appointed as Director since July 2010

Director 31-Jul-2010 Current
Mandira Chettri

Appointed as Director since July 2010

Director 31-Jul-2010 Current
Mridul Ranjan Khound

Appointed as Director since May 2010

Director 26-May-2010 Current

People Timeline

Explore the timeline of key personnel in Eliezer Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address House No.-30, Ward No.-52, Narengi Housing Colony Seujnagar, Narengi, Guwahati Assam, 781026, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 781026
  • Country India
  • Website -
Frequently Asked Questions
You can contact Eliezer Pharmaceuticals Private Limited through their registered address at House No.-30, Ward No.-52, Narengi Housing Colony Seujnagar, Narengi, Guwahati Assam, 781026, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Eliezer Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RAJIV LIMBOO
  • NIRMAL KUMAR TAMANG
  • MANDIRA CHETTRI
  • MRIDUL RANJAN KHOUND
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available